Longitudinal changes in HIV-1-specific T-cell quality associated with viral load dynamic

J Clin Virol. 2012 Oct;55(2):114-20. doi: 10.1016/j.jcv.2012.06.017. Epub 2012 Jul 13.

Abstract

Background: Several correlates of HIV control have been described; however their predictive values remain unclear, since most studies have been performed in cross-sectional settings.

Objectives: We evaluated the cause and consequence relationship between quality of HIV-specific T-cell response and viral load dynamic in a temporal perspective.

Study design: HIV-1-specific T-cell responses were monitored over 7 years in a patient that following treatment interruption maintained a stable/low viral set point for 3.1 years before control of viral replication was lost and antiretroviral therapy restarted.

Results: We observed that high frequencies of HIV-1-specific CD4 and CD8 T cells were unable to prevent loss of viral control. Gradual loss of functionality was observed in these responses, characterized by early loss of IL-2, viral load-dependent decrease of IFN-γ and CD154 expression as well as increase of MIP-1β production. Terminally differentiated HIV-1-specific CD8 T cells expressing CD45RA were lost independently of viral load and preceded the loss-of-control phase of HIV infection.

Conclusion: By describing qualitative changes in HIV-1-specific T-cell responses that coincide with loss of viral control, we identified specific correlates of disease progression and putative markers of viral control. Our findings suggest including the markers IL-2, IFN-γ, MIP-1β, CD154 and CD45RA into monitoring of HIV-specific T-cell-responses to prospectively determine correlates of protection from disease-progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • Biomarkers
  • CD40 Ligand / metabolism
  • Chemokine CCL4 / metabolism
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV Infections / virology*
  • HIV-1 / immunology
  • HIV-1 / isolation & purification*
  • Humans
  • Interferon-gamma / metabolism
  • Interleukin-2 / metabolism
  • Leukocyte Common Antigens / metabolism
  • Longitudinal Studies
  • Prognosis
  • T-Lymphocytes / immunology*
  • Viral Load*
  • Withholding Treatment

Substances

  • Anti-HIV Agents
  • Biomarkers
  • Chemokine CCL4
  • Interleukin-2
  • CD40 Ligand
  • Interferon-gamma
  • Leukocyte Common Antigens